Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and ...
With counterfeit drugs making up 30% of global sales, regulators are tightening serialisation and labelling rules to secure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback